PEG-MGF is a stabilized form of mechano growth factor, a splice variant of IGF-1 (often noted as IGF-1Ec) expressed in muscle following mechanical stress. PEGylation prolongs circulation time and protects the peptide from rapid degradation, enabling extended exposure in experimental models. It’s investigated for supporting muscle repair by promoting satellite-cell activation and early myogenic signaling, with exploratory work in connective tissue and neuroprotection contexts.

Research Focus:

• Skeletal muscle recovery after overload or eccentric damage (preclinical)
• Satellite-cell activation and early myogenesis signaling
• Attenuation of disuse or denervation atrophy models
• Tendon and connective-tissue healing studies
• Exploratory neuroprotective effects of MGF-derived sequences
• Local IGF-axis modulation and angiogenesis in injured tissue

Sources:

IGF-1Ec/MGF review (Frontiers in Endocrinology): https://www.frontiersin.org/articles/10.3389/fendo.2019.00625/full

MGF in neurogenesis/repair (PNAS): https://www.pnas.org/doi/10.1073/pnas.0402865101

Muscle regeneration signaling (American Journal of Physiology): https://journals.physiology.org/doi/full/10.1152/ajpendo.00252.2006

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.